Thomas Joseph Wilson, MD
Neurosurgery · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wilson’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A147670 · Current
Licensed to practise in California · since 2017 · expires 2027-03-31 · University of Nebraska College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$115,353
Medicare paid this office $115,353 for 251 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Incision or removal of spinal nerve | 25 | $12,062 | $464 |
| New patient visit (45+ min) | 87 | $9,877 | $114 |
| Release of arm or leg nerve | 20 | $6,475 | $270 |
| Return visit (30+ min) | 52 | $4,571 | $82 |
| Long return visit (40+ min) | 35 | $4,251 | $121 |
See all 10 services
| Incision or removal of spinal nerve | 25 | $12,062 | $464 |
| New patient visit (45+ min) | 87 | $9,877 | $114 |
| Release of arm or leg nerve | 20 | $6,475 | $270 |
| Return visit (30+ min) | 52 | $4,571 | $82 |
| Long return visit (40+ min) | 35 | $4,251 | $121 |
| Return visit (30+ min) | 22 | $2,220 | $101 |
| New patient visit (30+ min) | 21 | $2,148 | $102 |
| Deep biopsy of muscle | 14 | $1,574 | $105 |
| Short return visit (20+ min) | 27 | $1,546 | $57 |
| Short return visit (20+ min) | 17 | $1,476 | $87 |
Who their Medicare patients are
251 Original Medicare patients in 2024. Average age 70 · Women 50% · Also on Medicaid 20% · Health risk score 1.30. At or below the middle of the specialty; the typical neurosurgery clinician is at 1.46.
Conditions among them: High blood pressure 67% · Depression 26% · Diabetes 24% · Coronary heart disease 24% · Chronic kidney disease 18% · Cancer 17% · Atrial fibrillation 16% · Heart failure 10% · COPD 10% · Stroke 7%.
The office billed $796,689, Medicare allowed $148,273 and paid $115,353; for 478 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 251 | 478 | 70 | 1.30 | $796,689 | $115,353 |
| 2023 | 206 | 412 | 70 | 1.28 | $952,435 | $107,935 |
| 2022 | 190 | 398 | 70 | 1.32 | $619,866 | $90,939 |
| 2021 | 189 | 454 | 68 | 1.28 | $872,261 | $126,611 |
| 2020 | 129 | 292 | 68 | 1.41 | $661,879 | $97,618 |
| 2019 | 133 | 306 | 69 | 1.40 | $545,856 | $73,906 |
| 2018 | 119 | 279 | 69 | 1.45 | $428,237 | $61,230 |
| 2017 | 47 | 96 | 69 | 1.93 | $98,609 | $15,414 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Transfer of nerve to injured nerve, stage 1 of 2 | 11 | $14,688 | $773 |
| New patient visit (45+ min) | 85 | $10,156 | $119 |
| Return visit (30+ min) | 65 | $6,063 | $84 |
| Release and/or relocation of hand nerve | 12 | $5,031 | $335 |
| Long return visit (40+ min) | 27 | $3,711 | $128 |
| New patient visit (30+ min) | 13 | $985 | $76 |
| Short return visit (20+ min) | 11 | $671 | $61 |
2022: 5 services
| Return visit (30+ min) | 79 | $8,154 | $82 |
| New patient visit (45+ min) | 65 | $7,812 | $120 |
| Release of arm or leg nerve | 14 | $5,475 | $322 |
| Long return visit (40+ min) | 35 | $4,330 | $124 |
| New patient visit (30+ min) | 17 | $1,134 | $67 |
2021: 5 services
| New patient visit (45+ min) | 86 | $10,501 | $122 |
| Release of arm or leg nerve | 16 | $9,756 | $375 |
| Return visit (30+ min) | 69 | $7,566 | $87 |
| Release of arm or leg nerve | 14 | $6,489 | $324 |
| Long return visit (40+ min) | 27 | $3,427 | $122 |
2020: 5 services
| Creation of muscle graft to leg | 12 | $24,071 | $860 |
| Release of arm or leg nerve | 12 | $6,150 | $308 |
| New patient visit (45+ min) | 47 | $5,342 | $114 |
| Return visit (30+ min) | 33 | $2,549 | $67 |
| Long return visit (40+ min) | 27 | $2,516 | $93 |
2019: 5 services
| Release of arm or leg nerve | 15 | $6,375 | $290 |
| New patient visit (30+ min) | 48 | $3,073 | $64 |
| Return visit (30+ min) | 34 | $2,431 | $69 |
| Short return visit | 41 | $1,034 | $22 |
| Short return visit (20+ min) | 12 | $511 | $39 |
2018: 6 services
| Release of arm or leg nerve | 17 | $7,939 | $318 |
| New patient visit (30+ min) | 44 | $2,773 | $63 |
| Deep biopsy of muscle | 21 | $2,602 | $113 |
| New patient visit (30+ min) | 18 | $1,223 | $68 |
| Short return visit | 24 | $592 | $22 |
| Short return visit (20+ min) | 12 | $553 | $46 |
2017: 1 service
| New patient visit (45+ min) | 15 | $1,733 | $116 |
Drugs they prescribed that Part D paid
$206
Pharmacies billed $206 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 71% of their Part D prescriptions (20 of 28) in 2024. Too few prescriptions to compare fairly with other clinicians.
28 generic and 0 brand-name prescriptions · $206 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 14 | $115 | $8 |
Year by year
| 2024 | 28 | 22 | 71% (20) | 0% | $206 |
| 2023 | 23 | 20 | 52% (12) | 0% | $309 |
| 2022 | 51 | 27 | 31% (16) | 0% | $839 |
| 2021 | 26 | 19 | None | 0% | $315 |
| 2020 | 54 | 19 | 22% (12) | None | $1,130 |
| 2019 | 44 | 19 | 25% (11) | None | $5,345 |
| 2018 | 75 | 37 | None | None | $3,274 |
| 2017 | 20 | 12 | None | None | $252 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Gabapentin | 11 | $322 | $29 |
| Hydrocodone-Acetaminophen | 14 | $133 | $10 |
2020: 1 drug
| Pregabalin | 18 | $822 | $46 |
2018: 1 drug
| Cephalexin | 19 | $118 | $6 |
2017: 1 drug
| Cephalexin | 11 | $43 | $4 |
Money from drug and device companies
$383 in 2025
| 2025 | 3 | 4 | None | $383 |
| 2023 | 1 | 2 | $5,000 | $5,000 |
| 2022 | 2 | 3 | None | $128 |
| 2021 | 2 | 5 | $9,501 | $9,501 |
| 2019 | 2 | 2 | None | $50 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tulavi Therapeutics | Allay Nerve Cap - Small Nerve Set | $299 | 1 payment
|
| Medtronic | Corevalve Evolut R | $60 | 1 payment
|
| Axogen | None | $24 | 1 payment
|
See all 3 published payments
| Medtronic | Meals · 2025-10-26 | Corevalve Evolut R | $60 |
| Tulavi Therapeutics | Meals · 2025-10-11 | Allay Nerve Cap - Small Nerve Set | $299 |
| Axogen | Meals · 2025-09-20 | None | $24 |
See earlier years (2023, 2022, 2021, 2019)
2023: $5,000
| Bioventus | Stimrouter Implantable Kit | $5,000 | 2 payments
|
2022: $128
| Bioventus | Stimrouter Implantable Kit | $67 | 2 payments
|
| Axogen | Avance Nerve Graft | $61 | 1 payment
|
2021: $9,501
| AstraZeneca Pharmaceuticals LP | Koselugo | $6,176 | 4 payments
|
| Axogen | Avance Nerve Graft | $3,325 | 1 payment
|
2019: $50
| Axogen | Axoguard Nerve Connector | $31 | 1 payment
|
| Medtronic USA | Plasmablade | $19 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Checkpoint Surgical, Inc · Promoting Healing of Nerves Through Electrical Stimulation · 2024 | Their institution | $24,865 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194952416
- Licence
- CA A147670California A147670: Current · expires 2027-03-31
- Trained
- University of Nebraska College of Medicine, 2009
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207T00000X (207T00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2009-06-12
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.